About Bio2040
My name is Flavio Rump. I'm a Swiss/American entrepreneur and angel investor based in Zurich. I studied Electrical Engineering and Computational Biology (MSc) at ETH Zurich, cofounded DeinDeal (acquired by Ringier), and spent several years in Silicon Valley as a cofounder, early employee, and growth consultant.
Why Bio2040
I started asking myself why so much money was being invested into biomedical research, and why we still haven't found cures for so many diseases. To try to answer those questions, I talked to researchers, biotech CEOs, VCs, pharmaceutical executives, doctors, and other stakeholders to find out what the main challenges and opportunities are.
These conversations became Bio2040 — a podcast and blog documenting the bottlenecks in healthcare and drug discovery, and the people working to solve them. The episodes on this site were recorded between 2017 and 2022.
What's Next
The conversations from Bio2040 helped me navigate towards my current conviction. One of the biggest leverage points in biomedical research is better research tooling and orthogonal ideas. Researchers are often stuck in their bubble while the best ideas are interdisciplinary. I'm now working at a higher level of the stack — building AI for Science agents that help scientists turn breakthroughs into real-world impact.
To learn more about what I'm working on now, visit flaviorump.com.
Get in Touch
Email: flavio.rump@gmail.com
Twitter: @FlavioRump